Rheumatology News

• 'Doesn't Fit Anything I Trained for': Treating Chronic Lyme Researchers, clinicians, and patient advocates at a national meeting weighed in on efforts needed to accelerate research on treatments for chronic illness associated with Lyme disease.
  Medscape Medical News, July 26, 2024
• EULAR 2024 Taper, Dose Down, Discontinue: Striving for Less Steroid Use Now in the 75th year since the first presentation on the clinical use of glucocorticoids, what consensus has been reached in sparing their use to avoid their many potential adverse effects?
  Medscape Medical News, July 25, 2024
• GRAPPA 2024 MACE Risk Similar Among Biologics for Psoriasis, PsA A retrospective analysis shows no difference in major adverse cardiovascular events (MACE) between TNF inhibitors, IL-17 inhibitors, IL-23 inhibitors, and IL-12/IL-23 inhibitors.
  Medscape Medical News, July 25, 2024
• GRAPPA 2024 Adverse Events Differ Between Two Second-Line Psoriasis Rxs Apremilast and deucravacitinib, oral small-molecule drugs approved for treating psoriasis, were linked to different adverse events, and adverse event profiles differed between men and women.
  Medscape Medical News, July 25, 2024
• EULAR 2024 Breaking Rheumatology's Reliance on Steroids: New Strategies Selective GC receptor agonists and modulators and GC plus hydroxysteroid dehydrogenase inhibitor combination therapy are some of the approaches under consideration.
  Medscape Medical News, July 25, 2024
• GRAPPA 2024 MHC-1-Opathies Linked to Ancient Retrovirus Infections Psoriasis is one of several autoimmune diseases linked to variations in MHC-1 that may have protected our ancestors from retroviruses.
  Medscape Medical News, July 24, 2024
• US Drug Industry Middlemen Defend Business Model Amid Accusations Of Raising Patient Costs U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a Congressional hearing on Tuesday after committee members accused them of pushing...
  Reuters Health Information, July 23, 2024
• GRAPPA 2024 Psoriatic Arthritis Treatment Failure Tied to Key Factors Comorbidities, disease characteristics, and socioeconomic factors were linked to failure to respond to disease-modifying antirheumatic drugs in patients with psoriatic arthritis.
  Medscape Medical News, July 23, 2024
• SPD 2024 Pediatric Rheumatology/Dermatology Clinic: Benefits Explored Team members participate in a preclinic conference to review patient data and images, discuss relevant literature, and develop an approach to each patient.
  Medscape Medical News, July 23, 2024
• 1 in 5 With Rheumatologic Disease Face Financial Hardship Patients with rheumatologic disease were 29% more likely than those without such conditions to have difficulty paying medical bills. Here's how healthcare providers can help.
  Medscape Medical News, July 22, 2024
• Early RA Diagnosis and Treatment Lowers Treatment Costs Costs were as much as 316% higher in patients diagnosed and treated more than 12 weeks after symptom onset.
  Medscape Medical News, July 22, 2024
• SPD 2024 Colchicine Effective for Pediatric Aphthous Ulcers The findings come from a retrospective review of Mayo Clinic patients.
  Medscape Medical News, July 22, 2024
• Adjusting Opioid Prescriptions After ED Can Reduce Misuse Half of patients take five or fewer tablets in the 2 weeks after leaving the emergency department for a new pain condition, data suggest.
  Medscape Medical News, July 22, 2024
• GRAPPA 2024 MSK Symptoms, Psoriasis: Dermatologists or Rheumatologists? A dermatologist argues for a role to prevent psoriatic arthritis, but rheumatologist favors experience in diagnosis.
  Medscape Medical News, July 19, 2024
• GRAPPA 2024 Psoriasis: Tissue Resident Memory T Cells Play Complex Role The mixed role of tissue resident memory T cells in psoriasis treatment has prompted a call for changing functionality rather than eliminating these cells.
  Medscape Medical News, July 18, 2024
• Air Pollution and Genetics Conspire to Raise Psoriasis Risk Exposure to multiple air pollutants and genetic predisposition interact to markedly increase the incidence of psoriasis, a new study has revealed.
  Medscape News UK, July 17, 2024
• Long COVID & ME/CSF: The Similarities are Uncanny This is giving research into myalgic encephalomyelitis/chronic fatigue syndrome a much-needed boost, but more funding is still needed.
  Medscape News UK, July 16, 2024
• Romosozumab More Effective in Treatment-Naive Patients Prior antiresorptive therapy — especially longer term — blunted BMD responses to the medication at the lumbar spine and hip.
  Medscape Medical News, July 16, 2024
• Microwave Ablation Reduces Recurrent Monoarthritis Pain Microwave ablation was safe and effective as a long-term adjunct treatment for recurrent monoarthritis in patients resistant to medical therapy.
  Medscape Medical News, July 14, 2024
• EULAR 2024 Careful Steroid Tapering May Not Increase SLE Flares Discontinuation of glucocorticoids in patients with remitted SLE can be flare-free if done slowly over approximately 2 years.
  Medscape Medical News, July 11, 2024